Health Condition 1: K049- Other and unspecified diseases ofpulp and periapical tissues
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Anand G
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients diagnosed with odontogenic space infection. 2)Patients who are willing to get hospitalized for treatment. 3)Patients who are willing to give consent to participate in the study. 4)Patients with no significant medical history. (ASA I and ASA II).
Exclusion criteria
Exclusion criteria: 1)Patients with conditions that have high levels of presepsin and procalcitonin such as salivary gland infections, sinusitis, osteomyelitis, drug-induced osteonecrosis, trauma and secondary infections due to tumours, were excluded from this study. 2)Patients who are not willing get hospitalized for treatment. 3)Patients who are not willing to give consent to participate in the study. 4)Patients with significant medical history (ASA III and ASA IV). 5)Pregnant and lactating patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.The diagnostic value of Presepsin and Procalcitonin levels to prevent sepsis in odontogenic space infection. 2.The prognostic use of Presepsin and Procalcitonin in management of odontogenic space infection. Timepoint: first day and third day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.line of treatment plan 2.the risk of sepsis in patients with odontogenic space infection. 3.the duration of hospitalization of patients. Timepoint: first day and third day | — |
Countries
India
Contacts
Public ContactAnand G
Government Dental College & Hospital, Mumbai
Outcome results
None listed